Mentions in press and media 5
| Date | Title | Description |
| 29.11.2024 | Allink Biotherapeutics: A New Dawn in Oncology and Immunology | In the bustling world of biotechnology, Allink Biotherapeutics is making waves. The company recently secured $42 million in Series A financing, a significant leap forward in its mission to develop innovative therapeutics. This funding round... |
| 29.11.2024 | Allink Biotherapeutics Raises $42M in Series A Financing | Allink Biotherapeutics, a Beijing, China-based clinical-stage biotechnology company providing new bispecific antibody and antibody-drug conjugate (ADC) therapeutics, raised $42M in Series A funding. The round was led by Lanchi Ventures, wit... |
| 28.11.2024 | Lanchi Ventures Leads $42M Series A Financing
|